← Back to headlines

Can Bimekizumab Match IL-23 Inhibitors for Drug Survival After IL-17 Inhibitor Failure in Psoriasis?

This story is reported by Medscape. Read what other outlets are saying below, then open the original report for full details.

Can Bimekizumab Match IL-23 Inhibitors for Drug Survival After IL-17 Inhibitor Failure in Psoriasis? · NabkaNews